Kappa/Lambda Light-chain Typing in Alzheimer's Disease
dc.authorid | Şahin, Şevki/0000-0003-2016-9965 | en_US |
dc.authorid | Serteser, Mustafa/0000-0001-7868-7613 | en_US |
dc.authorid | akgun, emel/0000-0002-2750-6939 | en_US |
dc.authorid | Serdar, Muhittin/0000-0002-3014-748X | en_US |
dc.authorid | aksungar, fehime benli/0000-0002-7954-7177 | en_US |
dc.authorid | KOCA, SEBILE/0000-0003-0945-057X | en_US |
dc.authorid | Karşıdağ, Sibel/0000-0002-2887-9235 | en_US |
dc.contributor.author | Kaya, Zelal Zuhal | |
dc.contributor.author | Tuzuner, Mete Bora | |
dc.contributor.author | Şahin, Betul | |
dc.contributor.author | Akgün, Emel | |
dc.contributor.author | Aksungar, Fehime | |
dc.contributor.author | Koca, Sebile | |
dc.contributor.author | Serdar, Muhittin | |
dc.date.accessioned | 2024-07-12T21:37:51Z | |
dc.date.available | 2024-07-12T21:37:51Z | |
dc.date.issued | 2022 | en_US |
dc.department | [Belirlenecek] | en_US |
dc.description.abstract | Background: Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss and cognitive impairment. The diagnosis of Alzheimer's disease according to symptomatic events is still a puzzling task. Developing a biomarker-based, low-cost, and high-throughput test, readily applicable in clinical laboratories, dramatically impacts the rapid and reliable detection of the disease. Objective: This study aimed to develop an accurate, sensitive, and reliable screening tool for diagnosing Alzheimer's disease, which can significantly reduce the cost and time of existing methods. Methods: We have employed a MALDI-TOF-MS-based methodology combined with a microaffinity chromatography enrichment approach using affinity capture resins to determine serum kappa (kappa) and lambda (lambda) light chain levels in control and patients with AD. Results: We observed a statistically significant difference in the kappa light chain over lambda light chain (kappa LC/lambda LC) ratios between patients with AD and controls (mean difference -0,409; % 95 CI: -0.547 to -0.269; p<0.001). Our method demonstrated higher sensitivity (100.00%) and specificity (71.43%) for discrimination between AD and controls. Conclusion: We have developed a high-throughput screening test with a novel sample enrichment method for determining kappa LC/kappa LC ratios associated with AD diagnosis. Following further validation, we believe our test has the potential for clinical laboratories. | en_US |
dc.description.sponsorship | Acibadem Labmed Laboratories in Turkey; Scientific and Technological Research Council of Turkey (TUBITAK-Grant) [118C082] | en_US |
dc.description.sponsorship | This research was funded by Acibadem Labmed Laboratories in Turkey and supported by the 2244 Industrial Ph.D. program provided by The Scientific and Technological Research Council of Turkey (TUBITAK-Grant#118C082). | en_US |
dc.identifier.doi | 10.2174/1567205019666220131101334 | |
dc.identifier.endpage | 93 | en_US |
dc.identifier.issn | 1567-2050 | |
dc.identifier.issn | 1875-5828 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 35100957 | en_US |
dc.identifier.scopus | 2-s2.0-85125725716 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 84 | en_US |
dc.identifier.uri | https://doi.org/10.2174/1567205019666220131101334 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12415/6965 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000826095800008 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science Publ Ltd | en_US |
dc.relation.ispartof | Current Alzheimer Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | KY04307 | |
dc.subject | Alzheimer's Disease | en_US |
dc.subject | Maldi-Tof-Ms | en_US |
dc.subject | Screening Tool | en_US |
dc.subject | Microaffinity Chromatography | en_US |
dc.subject | Affinity Capture Resins | en_US |
dc.subject | Kappa Light Chain | en_US |
dc.subject | Ratio | en_US |
dc.subject | Lambda Light Chain Ratio | en_US |
dc.title | Kappa/Lambda Light-chain Typing in Alzheimer's Disease | en_US |
dc.type | Article | |
dspace.entity.type | Publication |